-transparent.png){kind=logo}
The urinary and biliary excretion of diflunisal and its glucuronide and sulphate conjugates were studied in 10 patients following cholecystectomy. Total urinary excretion (0-24 h) was 36.6 +/- 16.4% of the 250 mg dose. Biliary excretion (0-24 h) was restricted to the phenolic and acyl glucuronides and accounted for 3.7 +/- 2.3% of the dose. An inverse relationship existed between urinary and biliary excretion of diflunisal and its conjugates. The data indicate that the reduced plasma clearance of diflunisal in patients with renal failure may, at least in part, be due to increased biliary excretion of diflunisal glucuronides followed by hydrolysis in the gut and reabsorption of diflunisal i.e. enterohepatic cycling.
R K Verbeeck, and
R G Dickinson, and
S M Pond
July 1993,
Antimicrobial agents and chemotherapy,
R K Verbeeck, and
R G Dickinson, and
S M Pond
January 1982,
European journal of clinical pharmacology,
R K Verbeeck, and
R G Dickinson, and
S M Pond
January 1982,
The Journal of antimicrobial chemotherapy,
R K Verbeeck, and
R G Dickinson, and
S M Pond
July 1987,
[Kango gijutsu] : [Nursing technique],
R K Verbeeck, and
R G Dickinson, and
S M Pond
February 1971,
Minerva chirurgica,
R K Verbeeck, and
R G Dickinson, and
S M Pond
February 1983,
Military medicine,
R K Verbeeck, and
R G Dickinson, and
S M Pond
June 1961,
California medicine,
R K Verbeeck, and
R G Dickinson, and
S M Pond
January 1983,
Infection control : IC,
R K Verbeeck, and
R G Dickinson, and
S M Pond
December 1978,
JAMA,
R K Verbeeck, and
R G Dickinson, and
S M Pond
November 1953,
Toulouse medical,
